Ms. Janet Grove - 18 Feb 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Director
Signature
/s/ Bruce Colwill, attorney-in-fact for Ms. Janet P. Grove
Issuer symbol
INM
Transactions as of
18 Feb 2022
Net transactions value
$0
Form type
4
Filing time
22 Feb 2022, 19:16:17 UTC
Previous filing
22 Feb 2022
Next filing
19 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +14,000 $0.000000 14,000 18 Feb 2022 Common shares 14,000 $1.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 02/18/2022 with 390 stock options vesting on the 18th day of each of the 35 months commencing March 18, 2022 through January 18, 2025 and 350 stock options will vest on February 18, 2025.